The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Regulatory News (N4P)

Share Price Information for N4 Pharma Plc (N4P)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.715
Bid: 0.65
Ask: 0.70
Change: 0.09 (14.40%)
Spread: 0.05 (7.692%)
Open: 0.625
High: 0.715
Low: 0.715
Prev. Close: 0.625
N4P Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Order for Green Technology Products Division

5 Apr 2011 07:00

RNS Number : 2823E
Ultima Networks PLC
05 April 2011
 



For immediate release 5 April 2011

Ultima Networks plc

("Ultima" or the "Company")

€370,000 further new order for Green Technology Products Division

The Board of Ultima, the IT and Green Technology Company, are pleased to announce that UTN (the Green Technology Products Division) has received a further, major new order for its mainland European version of the Infineum electric bicycle. The order has a value of €370,000 to Ultima to be delivered by July 2011 with potential for follow-on orders in the future.

Orders for the new Infineum model now total €1.1 million since its launch in September 2010. UTN has despatched a total of 700 units to date in 2011 and the board remain confident that total volumes through EQ-Bikes will reach the division's target of 2,500 units during the calendar year. The bicycle is being marketed in Benelux countries by the division's Dutch distributor, EQ-Bikes.

Wazz Mughal, Managing Director of UTN, said:

"We are excited by the level of customer uptake in our Infineum Continental range of electric bicycles which has exceeded management's expectations. Total orders have now exceeded €1m since the launch of the new model at the end of last year. The Infineum range has been specifically designed to appeal to cyclists in the BENELUX region and the Board are confident that the launch of new models will further strengthen Ultima's market positioning and enable Ultima to continue to gain market share in continental Europe."

Enquiries:

Ultima Networks plc 01279 821200

Prof. Humayun Mughal

 

 

Allenby Capital Limited (nominated adviser and broker) 0203 328 5656

Nick Naylor

Nick Athanas

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFMGGDVDDGMZM
Date   Source Headline
16th Mar 202010:26 amRNSHolding(s) in Company
4th Mar 20207:00 amRNSPosting of Annual Report and Notice of AGM
25th Feb 20207:00 amRNSFinal Results
11th Feb 20207:00 amRNSResearch Collaboration Agreement
29th Jan 20207:00 amRNSUpdate on Nuvec® process improvements
18th Sep 20197:00 amRNSInterim Results
20th Aug 20197:00 amRNSResults of University of Queensland Study
13th Aug 201911:16 amRNSHolding(s) in Company
15th Jul 20192:05 pmRNSSecond Price Monitoring Extn
15th Jul 20192:00 pmRNSPrice Monitoring Extension
3rd Jul 20194:40 pmRNSSecond Price Monitoring Extn
3rd Jul 20194:35 pmRNSPrice Monitoring Extension
19th Jun 201912:51 pmRNSResult of AGM
19th Jun 20197:00 amRNSAGM Statement
14th Jun 20194:41 pmRNSSecond Price Monitoring Extn
14th Jun 20194:36 pmRNSPrice Monitoring Extension
28th May 20192:21 pmRNSChange to Director Shareholding
22nd May 20197:00 amRNSPosting of Annual Report and Notice of AGM
21st May 20197:00 amRNSBoard Changes
14th May 20197:00 amRNSFinal Results
15th Apr 20197:00 amRNSNuvec® Research update
10th Apr 201911:52 amRNSDirector/PDMR Shareholding
9th Apr 20197:00 amRNSNuvec® Research update
20th Mar 20199:40 amRNSHolding(s) in Company
20th Mar 20199:40 amRNSHolding(s) in Company
28th Feb 20195:00 pmRNSTotal Voting Rights
14th Feb 20192:14 pmRNSHolding(s) in Company
8th Feb 201912:23 pmRNSPlacing to raise £1.05 million
20th Dec 20187:00 amRNSNuvec licence extension
28th Nov 20187:00 amRNSNuvec® research update
16th Nov 20181:36 pmRNSNuvec resource changes
15th Nov 20187:00 amRNSFiling of further Nuvec® patent application
14th Nov 201811:05 amRNSSecond Price Monitoring Extn
14th Nov 201811:00 amRNSPrice Monitoring Extension
14th Nov 20189:05 amRNSSecond Price Monitoring Extn
14th Nov 20189:00 amRNSPrice Monitoring Extension
8th Nov 20184:40 pmRNSSecond Price Monitoring Extn
8th Nov 20184:35 pmRNSPrice Monitoring Extension
8th Nov 20182:05 pmRNSSecond Price Monitoring Extn
8th Nov 20182:00 pmRNSPrice Monitoring Extension
5th Nov 201811:06 amRNSSecond Price Monitoring Extn
5th Nov 201811:00 amRNSPrice Monitoring Extension
5th Nov 20189:00 amRNSPrice Monitoring Extension
5th Nov 20187:54 amRNSResearch collaboration update
29th Oct 20187:00 amRNSNuvec® research update
2nd Oct 201811:44 amRNSResearch collaboration for novel DNA vaccine
26th Sep 20181:48 pmRNSGrant of options
26th Sep 201811:00 amRNSPrice Monitoring Extension
24th Sep 20184:41 pmRNSSecond Price Monitoring Extn
24th Sep 20184:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.